# Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients

> **NCT01481805** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01481805
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-14
- **Primary completion:** 2014-01-13
- **Final completion:** 2014-08-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481805, "Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01481805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*